Related Experiment Video
Updated: Jul 15, 2026
10:14
Inguinal Subcutaneous White Adipose Tissue (ISWAT) Transplantation Model of Murine Islets
Published on: February 16, 2020
[Current status of islet transplantation]
José María Balibrea del Castillo1, Elena Vara Ameigeiras, Javier Arias-Díaz
1Departamento de Cirugía, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España. jose_balibrea@yahoo.es
Cirugia Espanola
|April 4, 2007
Summary
Clinical islet transplantation outcomes are improving due to advances in immunosuppression, donor selection, and islet isolation techniques. This review covers recent progress and new islet sources for better long-term success.
Area of Science:
- Endocrinology and Metabolism
- Transplantation Immunology
Context:
- Islet transplantation is a key therapy for type 1 diabetes.
- Significant advancements have been made in recent years.
Purpose:
- To review the clinical outcomes of islet transplantation.
- To correlate outcomes with recent procedural and scientific advances.
Summary:
- Improved immunosuppression protocols enhance long-term graft survival.
- Optimized donor selection and islet isolation techniques are crucial.
- Exploration of novel islet sources, including non-heart-beating donors, is expanding options.
- Enhanced understanding of rejection mechanisms aids prevention strategies.
Impact:
- Clinical islet transplantation is becoming increasingly successful.
- These advances offer improved quality of life for patients with diabetes.
- Future research directions in transplantation immunology and regenerative medicine.
